Skip to content

Immediate Implant Outcomes With and Without Bone Augmentation

Immediate Implants in Damaged Sockets With Simultaneous Bone Reconstruction vs. Immediate Implants in Intact Sockets and no Reconstruction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05157009
Enrollment
50
Registered
2021-12-14
Start date
2021-10-01
Completion date
2023-12-31
Last updated
2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Loss, Alveolar, Dental Diseases, Dental Trauma, Tooth Loss

Keywords

immediate dental implant, dental implant, bone regeneration, peri-implantitis

Brief summary

To evaluate immediate implant placement feasibility and esthetic outcomes in severely damaged sockets that received simultaneously bone reconstruction (cortical bone shield) and implant placement versus intact sockets that needed no reconstruction and had immediate implant placement.

Detailed description

The present clinical trial aims at demonstrating facial bone regeneration on sites that presented large buccal bone dehiscences & vertical bone loss and evaluate the feasibility of performing simultaneous bone augmentation and implant placement, comparing the outcomes with sites that had intact sockets that did not require reconstruction. A secondary objective was to evaluate pink esthetics and marginal bone levels at final follow-up.

Interventions

PROCEDUREimplant placement

autogenous bone reconstruction of damaged socket & simultaneous implant placement

Sponsors

Verdugo, Fernando, DDS
Lead SponsorINDIV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* individuals 20 Years and older * Patients requiring single implants to replace missing teeth to restore masticatory function and esthetics. * ASA1 or ASA2 (American Society of Anesthesiologists) * Healthy individuals with good oral hygiene and motivation * No systemic uncontrolled diseases * Not taking drugs known to modify bone metabolism

Exclusion criteria

* Individuals with untreated & generalized severe periodontitis * Smokers (\>5 cigarettes/day) * Poor oral hygiene * Diabetes (HbA1C \>6.5% as cutoff value) * Uncontrolled cardiovascular disease * Poor overall health (ASA IV)

Design outcomes

Primary

MeasureTime frameDescription
Evaluate implant placement feasibility & success rate at 12 months12 monthsevaluate implant success following Karoussis et al. success criteria
Number of individuals with low pink esthetic outcomes as assessed by pink esthetic scores (PES)12 monthspink esthetics scores (PES) as proposed by Belser et al. Values 0-10 were 10 is the best esthetic outcome.

Secondary

MeasureTime frameDescription
Implant transparency: clinical presence or absence12 monthsVisual evaluation of facial mucosal implant transparency at 12 months: positive or negative
Number of participants with >0.2mm of marginal bone levels12 monthsevaluate radiographic marginal bone levels at 12 months with \>0.2mm of bone loss
Band of keratinized tissue: clinical presence or absence12 monthsevaluate the presence of facial keratinized tissue on the implant sites \>2 or \<2mm

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026